Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance
November 05 2020 - 8:00AM
Business Wire
- Data presented at recent American Academy of Optometry meeting
demonstrates PRECISION1 rated superior over leading competitor
- Direct-to-consumer campaign in the U.S. delivers brand
engagement and furthers patient trial of PRECISION1 among new and
existing lens wearers
- PRECISION1 for Astigmatism launched to select U.S. eye care
practices, with broader availability planned in the U.S. and Europe
in early 2021
Alcon (SIX/NYSE: ALC), the global leader in eye care, announced
continued momentum of its PRECISION1® one-day, silicone hydrogel
(SiHy) contact lenses following strong reception by the U.S. Eye
Care Professional (ECP) community around its launch in late 2019.
Alcon is energizing doctors and patients with data affirming the
superior wearing experience of the lens, as well as the See What
Happens consumer campaign, featuring actress Katherine McNamara and
the PRECISION1 SEE FREE incentive program designed to drive patient
awareness and trials during COVID-19 recovery.
“With the unprecedented challenges this year, Alcon has pivoted
to meet Eye Care Professional and patient needs throughout the
COVID-19 pandemic,” said Sergio Duplan, President, Alcon North
America. “The commercial and consumer success of PRECISION1 in the
U.S. is not only a testament to the clinical performance of the
lens, but also speaks to the innovative and customer-centric
mindset of our teams who were at the ready with powerful programs
and compelling campaigns created to support practices as they began
to re-open and recover.”
The superior on-eye performance of PRECISION1 was highlighted in
clinical study findings presented at the recent American Academy of
Optometry annual meeting (October 7 – 22). A subjective preference
study showed the brand was rated significantly higher than the
leading competitor for key vision and performance indicators. In
the study, five times more patients “strongly preferred” PRECISION1
lenses over the leading daily disposable lens competitor. This
study also showed that wearers rated PRECISION1 significantly
higher than the leading daily disposable lens competitor for
overall quality of vision, end-of-day vision, overall comfort,
end-of-day comfort and overall handling including insertion and
removal (p≤0.015 for all).1
The brand is also partnering with actress Katherine McNamara for
its See What Happens consumer campaign to drive awareness and trial
of the lens among “Gen-Zennials” in their 20s. The campaign
includes a full-scale online ad and social media campaign and
partnerships with social media influencers detailing their
experiences with the lenses. Consumers are also encouraged to take
the interactive “Lens Love” quiz, download a free trial certificate
and find an eye doctor to try PRECISION1 contact lenses.
As part of the PRECISION1 SEE FREE program, Alcon is providing
exclusive patient savings through December 2020 to drive traffic to
practices while also delivering safe, convenient direct-to-patient
shipping.
“Like any other independent practice owner, the COVID-19
shutdown had a significant impact on my business and my ability to
do what I love – deliver quality eye care to my patients,” said Dr.
Eric Arneson, Hastings Vision Clinic, Nebraska. “When my doors
opened back up, the PRECISION1 SEE FREE program allowed me to
engage my patients with a great incentive program to drive trials,
which often resulted in annual supply purchases. This helps drive
compliant contact lens wear with a product that delivers a great
on-eye experience.”
PRECISION1 sphere contact lenses are currently available in the
U.S. and will be rolling out to additional markets in late 2020
into 2021. To build on this momentum, Alcon is currently
introducing PRECISION1 for Astigmatism contact lenses in the U.S.
to select eye care practices, with broader availability planned in
the U.S. and Europe in early 2021. Recently presented clinical data
for PRECISION1 for Astigmatism lenses found exceptional on-eye
stability, which supports visual performance for patients with
astigmatism.2
Wearing contact lenses requires a prescription. Ask your Eye
Care Professional for complete wear, care and safety
information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. In particular, our
expectations could be affected by uncertainties regarding the
success of our separation and spin-off from Novartis. Should one or
more of these uncertainties or risks materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those anticipated. Therefore, you should not rely
on any of these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date of its filing, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
References
- Miller J, Giedd B, Subbaraman L. Clinical comparison of
verofilcon A and etafilcon A daily disposable contact lenses.
Poster presented at virtual American Academy of Optometry 2020
annual meeting; October 7 - 22, 2020.
- Movic W, Giedd B, Subbaraman L. Clinical performance of
verofilcon A toric daily disposable silicone hydrogel contact
lenses. Poster presented at virtual American Academy of Optometry
2020 annual meeting; October 7 - 22, 2020.
Connect with us on
Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201105005335/en/
Alcon Media Relations
Kimberly Wise +1 (817) 615 5092 (direct) +1 (817) 525 3409 (mobile)
kimberly.wise@alcon.com
Alcon Investor Relations
Christina Cheng +41 589 112 110 (Geneva) +1 817 615 2789 (Fort
Worth) investor.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From May 2024 to Jun 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2023 to Jun 2024